C. Orla Morrissey

Attributable Hospital Cost and Antifungal Treatment of Invasive Fungal Diseases in High-Risk Hematology Patients: an Economic Modeling Approach

Michelle Ananda‐Rajah, Allen Cheng, C. Orla Morrissey et al. · Antimicrobial Agents and Chemotherapy · 2011 · 83 citations · Full text

Pharmacy, Pharmacoeconomics, Cost-benefit Analysis +16

Isavuconazole as salvage therapy for mucormycosis

Bianca Graves, C. Orla Morrissey, Andrew H. Wei et al. · Medical Mycology Case Reports · 2016 · 45 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

<i>Scedosporium apiospermum</i> and <i>Lomentospora prolificans</i> in lung transplant patients – A single center experience over 24 years

Jaideep Vazirani, Glen Westall, Gregory I. Snell et al. · Transplant Infectious Disease · 2020 · 20 citations

Veterinary Medicine, Infectious Diseases, Microbiology +17

Introduction to the updated Australasian consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting, 2021

Christina C. Chang, Christopher C. Blyth, Sharon C.‐A. Chen et al. · Internal Medicine Journal · 2021 · 16 citations · Full text

Pharmacy, Infectious Diseases, Microbiology +17

Utility of a proposed CSP typing nomenclature for Australian Aspergillus fumigatus isolates: Identification of additional CSP types and suggested modifications

Sarah Kidd, Nik A.A. Nik Zulkepeli, Monica A. Slavin et al. · Journal of Microbiological Methods · 2009 · 15 citations

Life Sciences, Biology, Microbiology +13